These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4648 related items for PubMed ID: 16533572

  • 1. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 2. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
    Garrido-Gil P, Belzunegui S, San Sebastián W, Izal-Azcárate A, López B, Marcilla I, Luquin MR.
    J Neurosci Res; 2009 Feb 19; 87(2):586-97. PubMed ID: 18798285
    [Abstract] [Full Text] [Related]

  • 3. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact.
    Lau YS, Novikova L, Roels C.
    Neurosci Res; 2005 Aug 19; 52(4):371-8. PubMed ID: 15936837
    [Abstract] [Full Text] [Related]

  • 4. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW.
    Brain Res; 2007 May 30; 1150():55-61. PubMed ID: 17397812
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E, Csillik B, Pákáski M, Krisztin-Péva B, Dobó E, Okuno E, Vécsei L.
    Neuroscience; 2004 May 30; 126(4):899-914. PubMed ID: 15207325
    [Abstract] [Full Text] [Related]

  • 6. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 30; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 7. Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment.
    Lee JY, Son HJ, Choi JH, Cho E, Kim J, Chung SJ, Hwang O, Koh JY.
    Brain Res; 2009 Aug 25; 1286():208-14. PubMed ID: 19559009
    [Abstract] [Full Text] [Related]

  • 8. Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease.
    He XJ, Yamauchi H, Uetsuka K, Nakayama H.
    Neurotoxicology; 2008 May 25; 29(3):413-20. PubMed ID: 18387672
    [Abstract] [Full Text] [Related]

  • 9. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 25; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 10. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
    Xu G, Xiong Z, Yong Y, Wang Z, Ke Z, Xia Z, Hu Y.
    Neuroscience; 2010 Apr 28; 167(1):174-84. PubMed ID: 20123001
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 28; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 12. Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.
    Alladi PA, Mahadevan A, Yasha TC, Raju TR, Shankar SK, Muthane U.
    Neuroscience; 2009 Mar 03; 159(1):236-45. PubMed ID: 19135503
    [Abstract] [Full Text] [Related]

  • 13. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Chera B, Schaecher KE, Rocchini A, Imam SZ, Sribnick EA, Ray SK, Ali SF, Banik NL.
    Brain Res; 2004 May 01; 1006(2):150-6. PubMed ID: 15051518
    [Abstract] [Full Text] [Related]

  • 14. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR.
    Eur J Neurosci; 2009 Mar 01; 29(5):954-63. PubMed ID: 19245367
    [Abstract] [Full Text] [Related]

  • 15. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W, Sripanichkulchai K, Finkelstein DI.
    Brain Res; 2006 Apr 21; 1084(1):28-37. PubMed ID: 16564034
    [Abstract] [Full Text] [Related]

  • 16. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.
    Barcia C, Sánchez Bahillo A, Fernández-Villalba E, Bautista V, Poza Y Poza M, Fernández-Barreiro A, Hirsch EC, Herrero MT.
    Glia; 2004 May 21; 46(4):402-9. PubMed ID: 15095370
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2006 Dec 21; 24(11):3174-82. PubMed ID: 17156378
    [Abstract] [Full Text] [Related]

  • 18. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 21; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 19. Evidence of apoptosis in the subventricular zone and rostral migratory stream in the MPTP mouse model of Parkinson disease.
    He XJ, Nakayama H, Dong M, Yamauchi H, Ueno M, Uetsuka K, Doi K.
    J Neuropathol Exp Neurol; 2006 Sep 21; 65(9):873-82. PubMed ID: 16957581
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Goldberg NR, Haack AK, Lim NS, Janson OK, Meshul CK.
    Neuroscience; 2011 Apr 28; 180():256-71. PubMed ID: 21335067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 233.